Jennifer Schranz Net Worth & Insider Trades

Jennifer Schranz - Chief Medical Officer, Nabriva Therapeutics Plc

As of March 2, 2021

What is Jennifer Schranz's Net Worth?

The current estimated net worth of Nabriva Therapeutics Plc's Chief Medical Officer, Jennifer Schranz, is estimated to be about $101.5K . Jennifer Schranz owns about 5,500 units of Nabriva Therapeutics Plc common stock. In the last 3 years at Nabriva Therapeutics Plc, Jennifer Schranz has sold an estimated value of $8.19K worth.

What is Jennifer Schranz's Past Insider Trading?

Jennifer Schranz's largest purchase order was 5,500 units , worth over $20.52K on June 25, 2018. In total, Jennifer Schranz has made about 18 transactions over 3 years of their time at Nabriva Therapeutics Plc. Jennifer Schranz usually trades in February, with the busiest year in 2020.

Jennifer Schranz

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Jennifer Schranz's Salary in 2020?

As Chief Medical Officer of Nabriva Therapeutics Plc, Jennifer Schranz has a total base salary of $460,000 . Jennifer Schranz received compensation valued at about $1,074,113 in 2020 after becoming Chief Medical Officer. The vast majority of their compensation came in the form of a bonus of $100,000 , other earnings, plans or compensations of $145,203 , option awards of $156,818 , other earnings, plans or compensations of $145,203 , and other compensation of $28,604 .

What is Jennifer Schranz's' Mailing Address?

  • Mailing address is 1000 Continental Drive Suite 600 King of Prussia PA 19406 PA

Nabriva Therapeutics Plc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Theodore Schroeder 2020 $576,800 - $242,256 $339,625 $242,256 $31,759 $1,654,570
Theodore Schroeder 2019 $560,000 - $119,250 $478,367 $119,250 $28,372 $1,496,164
Steven Gelone 2020 $486,300 - $153,185 $231,493 $153,185 $12,675 $1,154,516
Steven Gelone 2019 $472,100 - $181,420 $309,859 $181,420 $13,976 $1,178,280
Jennifer Schranz 2020 $460,000 $100,000 $145,203 $156,818 $145,203 $28,604 $1,074,113
Jennifer Schranz 2019 $436,200 - $151,200 $261,555 $151,200 $33,450 $982,155
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1641640/000110465921088033/tm2119969-2_def14a.htm

What are Nabriva Therapeutics Plc's Past Insider Trades?

Nabriva Therapeutics Plc's most recent insider trade came on August 4, 2022 by Daniel Burgess who sold 11,341 units worth $2.16K . In the last 5 years, insiders at Nabriva Therapeutics Plc have sold an estimated value of $5.26M and bought an estimated value of $1.22M worth of shares. Insider trading is most common in August, with the busiest year in 2021. The most active traders at the company are Steven Gelone, President and COO,  Theodore Schroeder, Chief Executive Officer,  and Robert Crotty, Gen Counsel & Corp Secretary .

Nabriva Therapeutics Legacy plc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1